Nuveen’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $253M | Sell |
|
|||||
|
2025
Q1 | $149M | Buy |
|
|||||
|
2024
Q4 | $106M | Buy |
|
|||||
|
2024
Q3 | $121M | Sell |
|
|||||
|
2024
Q2 | $143M | Buy |
|
|||||
|
2024
Q1 | $76.5M | Sell |
|
|||||
|
2023
Q4 | $104M | Sell |
|
|||||
|
2023
Q3 | $96.8M | Sell |
|
|||||
|
2023
Q2 | $105M | Sell |
|
|||||
|
2023
Q1 | $122M | Sell |
|
|||||
|
2022
Q4 | $147M | Sell |
|
|||||
|
2022
Q3 | $3.32B | Buy |
|
|||||
|
2022
Q2 | $43.3M | Sell |
|
|||||
|
2022
Q1 | $58.8M | Sell |
|
|||||
|
2021
Q4 | $100M | Sell |
|
|||||
|
2021
Q3 | $145M | Buy |
|
|||||
|
2021
Q2 | $111M | Buy |
|
|||||
|
2021
Q1 | $84.1M | Sell |
|
|||||
|
2020
Q4 | $77.8M | Buy |
|
|||||
|
2020
Q3 | $62.2M | Sell |
|
|||||
|
2020
Q2 | $67.2M | Sell |
|
|||||
|
2020
Q1 | $56M | Buy |
|
|||||
|
2019
Q4 | $46.5M | Sell |
|
|||||
|
2019
Q3 | $33.5M | Buy |
|
|||||
|
2019
Q2 | $28.3M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $6.42K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $10.6M | Sell |
|
|||||
|
2014
Q3 | $15.9M | Buy |
|
|||||
|
2014
Q2 | $11.1M | Buy |
|
|||||
|
2014
Q1 | $11.5M | Buy |
|
|||||
|
2013
Q4 | $3.25M | Sell |
|
|||||
|
2013
Q3 | $3.52M | Buy |
|